The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Quinolones Global Market Report 2024, the quinolones market is expected to show promising growth in the forecast period.

The quinolones market has exhibited consistent growth, with a notable increase from $48.31 billion in 2023 to an anticipated $50.65 billion in 2024. This growth is attributed to various factors, including antibiotic demand, regulatory approvals, research and development initiatives, a competitive landscape, and patent expirations. Looking ahead, the market is expected to maintain its upward trajectory, reaching $61.51 billion in 2028, with a compound annual growth rate (CAGR) of 5.0%. The forecasted growth factors include emerging diseases, regulatory changes, global health policies, rising antibiotic resistance, and strategic market expansion.

Rising Threat of Antimicrobial Resistance as a Growth Catalyst

– Antimicrobial Resistance (AMR) Overview

The increasing danger of antimicrobial resistance serves as a catalyst for the quinolones market’s sustained growth. AMR refers to the ability of microorganisms to resist the effects of antimicrobial drugs. Quinolones, known for their broad spectrum of activity against various bacteria, are becoming crucial in combating severe antibiotic-resistant infections.

– Alarming Statistics

In November 2022, the United Kingdom Health Security Agency reported a 2.2% increase in the predicted total number of severe antibiotic-resistant infections in England in 2021. This underlines the urgency of addressing antimicrobial resistance, further propelling the demand for quinolones.

Major Players Shaping the Quinolones Market

A multitude of prominent companies contributes to the dynamics of the quinolones market. Notable players include:

• Bayer AG
• Novartis AG
• Sanofi SA
• Johnson & Johnson Services Inc.
• Merck & Co. Inc.
• LG Life Sciences
• Allergan Inc.
• Pfizer Inc.
• Viatris Inc.
• Lupin Limited

View More On The Quinolones Market Report 2024 – https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report

Pinnacle Role of Product Innovation in the Dynamic Quinolones Market

– Innovative Products Shaping the Landscape

Product innovation emerges as a central trend, with key market players dedicating efforts to develop groundbreaking products. For instance, Viatris, a leading pharmaceutical company, launched Dovprela in January 2023. This new drug-resistant tuberculosis treatment reduces the treatment period significantly, showcasing the rapid anti-tuberculosis effect of quinolones.

Bausch + Lomb’s Strategic Acquisition: A Paradigm Shift in Ophthalmic Pharmaceuticals

– Acquisition Overview

In June 2023, Bausch + Lomb Incorporated made waves in the industry by acquiring Novartis International AG, a Switzerland-based pharmaceutical company, for an undisclosed amount. This strategic move aimed to restructure Bausch & Lomb’s pharmaceutical division, providing the necessary scale to lead in ocular surface disorders.

– Diversification and Advancements

The acquisition introduced new product opportunities to Bausch + Lomb, including librates, a compound for chronic ocular surface pain treatment, and AcuStream technology, enhancing accurate dosing and delivery of topical ophthalmic medications.

Segmenting the Quinolones Market

– By Type

The quinolones market is segmented by type, including Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, and Other Types.

– By Pathogen Type

Further segmentation considers the pathogen type, distinguishing between Gram-Positive Pathogen and Gram-Negative Pathogen.

– By Application

The market is also segmented by application, with categories such as Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.

North America: The Leading Region in 2023

– Regional Dominance

In 2023, North America emerged as the largest region in the quinolones market, emphasizing the region’s pivotal role in driving market growth.

In conclusion, the quinolones market is witnessing a dynamic shift driven by factors such as the rising threat of antimicrobial resistance, strategic acquisitions, and a focus on product innovation. As major players navigate through these changes, the market is poised for continued growth, presenting opportunities for both industry stakeholders and patients alike.

Request A Sample Of The Global Quinolones Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=9429&type=smp